International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members); Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members); Independent Reviewers; Isabel Fragata

doi:10.1016/j.healun.2021.07.012

International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members), Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members), Independent Reviewers, Isabel Fragata

Resultado de pesquisa › revisão de pares

23 Citações (Scopus)

Idioma original	English
Páginas (de-até)	1327-1348
Número de páginas	22
Revista	Journal of Heart and Lung Transplantation
Volume	40
Número de emissão	11
DOIs	https://doi.org/10.1016/j.healun.2021.07.012
Estado da publicação	Publicado - nov. 2021
Publicado externamente	Sim

Acesso ao documento

10.1016/j.healun.2021.07.012

Outros arquivos e links

Link to publication in Scopus

Citação

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members), Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members), Independent Reviewers, & Fragata, I. (2021). International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. Journal of Heart and Lung Transplantation, 40(11), 1327-1348. https://doi.org/10.1016/j.healun.2021.07.012

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members) ; Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members) ; Independent Reviewers et al. / International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. Em: Journal of Heart and Lung Transplantation. 2021 ; Vol. 40, N.º 11. pp. 1327-1348.

@article{d93b9209327e4b888656e7e8914f6e9c,

title = "International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document",

keywords = "Complications, Expert recommendations, Lung transplantation, Primary graft dysfunctions, Survival",

author = "{Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members)} and {Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members)} and {Independent Reviewers} and Nandor Marczin and {de Waal}, {Eric E.C.} and Hopkins, {Peter M.A.} and Mulligan, {Michael S.} and Andre Simon and Shaw, {Andrew D.} and {Van Raemdonck}, Dirk and Arne Neyrinck and Gries, {Cynthia J.} and Lars Algotsson and Laszlo Szegedi and {von Dossow}, Vera and Aidan Burrell and Paula Carmona and Donna Greenhalgh and Dominik H{\"o}chter and Bessie Kachulis and King, {Christopher S.} and Licker, {Marc J.} and McIlroy, {David R.} and Priya Nair and Daniela Pasero and David Pilcher and Steffen Rex and David Royston and Peter Slinger and Franco Valenza and Chris Walker and Antonio Arcadipane and Oliver Bastien and Bekkers, {Joseph A.} and Dominique Bettex and Francesca Caliandro and Checco, {Erika Dal} and Davis, {Robert Duane} and G{\"o}ran Dellgren and Andreas Espinoza and Felten, {Marie Louise} and Paolo Feltracco and Marc Fischler and Fitzgerald, {Linda J.} and Forner, {Ana Flo} and Isabel Fragata and Rom{\'a}n, {Ana Gonz{\'a}lez} and Paul Harris and Matthias Hommel and Lees, {Nicholas J.} and Guen, {Morgan Le} and Marc Leone and Thierry Lepoivre",

note = "Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Nandor Marczin reports personal fees from Linde, grants and personal fees from Cytosorbents Inc, outside the submitted work. Eric E.C. de Waal reports personal fees from Abbott, grants and personal fees from Cytosorbents, outside the submitted work. Andrew D. Shaw reports personal fees from Edwards Lifesciences, from FAST BioMedical, and from Astellas Pharma, outside the submitted work. Vera von Dossow reports speakers{\textquoteright} fees from Orion Pharma outside the submitted work. Christopher King reports personal fees from Actelion, Genentech, United Therapeutics, and Boehringer Ingelheim Pharmaceuticals, outside the submitted work. Steffen Rex reports personal fees from Orion Pharma and Edwards Lifesciences, grants and personal fees from Nordic Pharma, grants from AirLiquide, outside the submitted work. G{\"o}ran Dellgren reports grants from Astellas for ScanCLAD study (ClinicalTrials.gov Identifier: NCT02936505), grants from Abbott for SweVAD study (ClinicalTrials.gov Identifier: NCT02592499), personal fees from XVIVO speakers bureau, outside the submitted work. Ana Gonz{\'a}lez Rom{\'a}n reports economical support from Abbott and Orion Laboratories, outside the submitted work. Morgan Le Guen reports personal fees from General Electric, and Fisher and Paykel, outside the submitted work. Marc Leone reports personal fees from MSD, Amomed, Aspen, and Gilead, outside the submitted work. Bertrand Rozec reports personal fees from LFB, AMOMED, Nordic Pharma, Medtronic, 3M, Aspen, and grants from Aguettant and Baxter, outside the submitted work. Shiva M. Sale reports speaker fees from St Jude, outside the submitted work. Robert Duane Davis and Vincent G. Valentine did not disclose conflict of interests. All other authors have no disclosures to report. ",

year = "2021",

month = nov,

doi = "10.1016/j.healun.2021.07.012",

language = "English",

volume = "40",

pages = "1327--1348",

journal = "Journal of Heart and Lung Transplantation",

issn = "1053-2498",

publisher = "Elsevier USA",

number = "11",

}

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members), Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members), Independent Reviewers & Fragata, I 2021, 'International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document', Journal of Heart and Lung Transplantation, vol. 40, n.º 11, pp. 1327-1348. https://doi.org/10.1016/j.healun.2021.07.012

International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. / Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members); Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members); Independent Reviewers et al.
Em: Journal of Heart and Lung Transplantation, Vol. 40, N.º 11, 11.2021, p. 1327-1348.

Resultado de pesquisa › revisão de pares

TY - JOUR

T1 - International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document

AU - Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members)

AU - Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members)

AU - Independent Reviewers

AU - Marczin, Nandor

AU - de Waal, Eric E.C.

AU - Hopkins, Peter M.A.

AU - Mulligan, Michael S.

AU - Simon, Andre

AU - Shaw, Andrew D.

AU - Van Raemdonck, Dirk

AU - Neyrinck, Arne

AU - Gries, Cynthia J.

AU - Algotsson, Lars

AU - Szegedi, Laszlo

AU - von Dossow, Vera

AU - Burrell, Aidan

AU - Carmona, Paula

AU - Greenhalgh, Donna

AU - Höchter, Dominik

AU - Kachulis, Bessie

AU - King, Christopher S.

AU - Licker, Marc J.

AU - McIlroy, David R.

AU - Nair, Priya

AU - Pasero, Daniela

AU - Pilcher, David

AU - Rex, Steffen

AU - Royston, David

AU - Slinger, Peter

AU - Valenza, Franco

AU - Walker, Chris

AU - Arcadipane, Antonio

AU - Bastien, Oliver

AU - Bekkers, Joseph A.

AU - Bettex, Dominique

AU - Caliandro, Francesca

AU - Checco, Erika Dal

AU - Davis, Robert Duane

AU - Dellgren, Göran

AU - Espinoza, Andreas

AU - Felten, Marie Louise

AU - Feltracco, Paolo

AU - Fischler, Marc

AU - Fitzgerald, Linda J.

AU - Forner, Ana Flo

AU - Fragata, Isabel

AU - Román, Ana González

AU - Harris, Paul

AU - Hommel, Matthias

AU - Lees, Nicholas J.

AU - Guen, Morgan Le

AU - Leone, Marc

AU - Lepoivre, Thierry

N1 - Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Nandor Marczin reports personal fees from Linde, grants and personal fees from Cytosorbents Inc, outside the submitted work. Eric E.C. de Waal reports personal fees from Abbott, grants and personal fees from Cytosorbents, outside the submitted work. Andrew D. Shaw reports personal fees from Edwards Lifesciences, from FAST BioMedical, and from Astellas Pharma, outside the submitted work. Vera von Dossow reports speakers’ fees from Orion Pharma outside the submitted work. Christopher King reports personal fees from Actelion, Genentech, United Therapeutics, and Boehringer Ingelheim Pharmaceuticals, outside the submitted work. Steffen Rex reports personal fees from Orion Pharma and Edwards Lifesciences, grants and personal fees from Nordic Pharma, grants from AirLiquide, outside the submitted work. Göran Dellgren reports grants from Astellas for ScanCLAD study (ClinicalTrials.gov Identifier: NCT02936505), grants from Abbott for SweVAD study (ClinicalTrials.gov Identifier: NCT02592499), personal fees from XVIVO speakers bureau, outside the submitted work. Ana González Román reports economical support from Abbott and Orion Laboratories, outside the submitted work. Morgan Le Guen reports personal fees from General Electric, and Fisher and Paykel, outside the submitted work. Marc Leone reports personal fees from MSD, Amomed, Aspen, and Gilead, outside the submitted work. Bertrand Rozec reports personal fees from LFB, AMOMED, Nordic Pharma, Medtronic, 3M, Aspen, and grants from Aguettant and Baxter, outside the submitted work. Shiva M. Sale reports speaker fees from St Jude, outside the submitted work. Robert Duane Davis and Vincent G. Valentine did not disclose conflict of interests. All other authors have no disclosures to report.

PY - 2021/11

Y1 - 2021/11

KW - Complications

KW - Expert recommendations

KW - Lung transplantation

KW - Primary graft dysfunctions

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85121606778&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2021.07.012

DO - 10.1016/j.healun.2021.07.012

M3 - Article

C2 - 34732281

AN - SCOPUS:85121606778

SN - 1053-2498

VL - 40

SP - 1327

EP - 1348

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

IS - 11

ER -

Task force Chairs and Writing Group (exclusive of the consensus developing and coordinating group members), Consensus members (exclusive of the consensus developing and coordinating group or co-chairs and writing group members), Independent Reviewers, Fragata I. International consensus recommendations for anesthetic and intensive care management of lung transplantation. An EACTAIC, SCA, ISHLT, ESOT, ESTS, and AST approved document. Journal of Heart and Lung Transplantation. 2021 nov.;40(11):1327-1348. doi: 10.1016/j.healun.2021.07.012